Lusine Harutyunyan, PA

Lusine Harutyunyan practices at Cedars-Sinai Medical Care Foundation in Beverly Hills, California.

Lusine Harutyunyan's NPI, 1528270303, was assigned on May 4, 2007. Lusine Harutyunyan holds California license PA 18776.

Lusine Harutyunyan's primary practice is Cedars-Sinai Medical Care Foundation, at 8501 Wilshire Blvd, Beverly Hills, CA 90211 in Los Angeles County. The practice phone is (310) 385-3200.

Lusine Harutyunyan's primary practice is Cedars-Sinai Medical Care Foundation in Beverly Hills, California. Lusine Harutyunyan is also affiliated with Cedars-Sinai Medical Center. The medical group on file is Cedars-Sinai Medical Group. Dmand AI also links Lusine Harutyunyan to 1 more group practice or clinic and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Lusine Harutyunyan practices, 2 sites in all. Vendor and product names are available with a free account.

Physician assistant is Lusine Harutyunyan's primary specialty in the NPI Registry, under taxonomy code 363A00000X. Lusine Harutyunyan is board certified in certified in cardiovascular knowledge by the American College of Cardiology. Lusine Harutyunyan is licensed in California.

Dmand AI lists fluid and electrolyte imbalances, fluid in a joint, mobility impairment, sleep apnea and tobacco use among the conditions Lusine Harutyunyan treats.

CMS data shows 1,096 Medicare services from Lusine Harutyunyan across 6 procedure codes in 2024, for 517 Medicare patients. Medicare paid $56,433 for them. Every service was in an office.

CMS counts 517 Medicare patients who saw Lusine Harutyunyan in 2024. The largest group is 75 to 84, with 208 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 44% are also on Medicaid. Their average risk score is 1.45, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Lusine Harutyunyan's median patient age at 76, with 40% women.

In 2024, Lusine Harutyunyan wrote 2,812 Medicare Part D claims for 430 patients. 77% of them were for generic drugs. CMS names the drug for 2,557 of them, across 43 drugs with 11 or more claims each, at $463,364 in total drug cost.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 96 out of 100 for Lusine Harutyunyan for performance year 2024, reported through an alternative payment model (APM). Lusine Harutyunyan accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Lusine Harutyunyan as offering telehealth.

CMS Open Payments shows 124 general payments to Lusine Harutyunyan from 27 drug and device companies from 2024 to 2025. Food and beverage make up the largest share, 100% of the total. Boehringer Ingelheim Pharmaceuticals, Inc. paid the most, $553.